LACK OF EFFECT OF PROLACTIN SUPPRESSION ON PLASMA DEHYDROEPIANDROSTERONE SULPHATE
- 1 May 1979
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 10 (5), 539-544
- https://doi.org/10.1111/j.1365-2265.1979.tb02112.x
Abstract
In 12 patients with hyperprolactinemia, treatment which reduced plasma prolactin from a mean of 531 .mu.g/l (range 68-3500 .mu.g/l) to 8.3 .mu.g/l (0-27 .mu.g/l), caused no significant change in plasma dehydroepiandrosterone sulfate (DHA-SO4). Pre-treatment levels of DHA-SO4 were within the normal range in 11 of 12 cases. Claims that prolactin excess is associated with an increase in circulating DHA-SO4 are not supported.This publication has 11 references indexed in Scilit:
- PROLACTIN AND ADRENAL ANDROGEN SECRETIONClinical Endocrinology, 1978
- ADRENAL ANDROGENS IN PATIENTS WITH CHRONIC MARKED ELEVATION OF PROLACTINClinical Endocrinology, 1978
- Adrenocortical Function in Hyperprolactinemic WomenJournal of Clinical Endocrinology & Metabolism, 1977
- PLASMA ANDROGENS IN WOMEN WITH HYPERPROLACTINAEMIC AMENORRHOESClinical Endocrinology, 1977
- Dehydroepiandrosterone sulfate in plasma: hydrolysis, extraction and radioimmunoassaySteroids, 1976
- A radioimmunoassay for the estimation of serum dehydroepiandrosterone sulphate in normal and pathological seraClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- A RAPID RADIOIMMUNOASSAY FOR DETERMINATION OF DEHYDROEPIANDROSTERONE SULPHATE IN HUMAN PLASMAClinical Endocrinology, 1975
- Assay of plasma dehydroepiandrosterone and its sulphate by competitive protein bindingClinica Chimica Acta; International Journal of Clinical Chemistry, 1973
- Radioligand assay for Δ5-3β-hydroxysteroids I. 3β-hydroxy-5-androstene-17-one and its 3-sulfateSteroids, 1972
- Role of ACTH in the Secretion of Free Dehydroepiandrosterone and Its Sulfate Ester in ManJournal of Clinical Endocrinology & Metabolism, 1969